Role of iron in hepatocellular carcinoma.
作者信息
Fargion Silvia, Valenti Luca, Fracanzani Anna Ludovica
机构信息
Fondazione Cà Granda, IRCCS, Ospedale Maggiore Policlinico, Physiopatology and Liver Transplantation Department University of Milan Milan Italy.
出版信息
Clin Liver Dis (Hoboken). 2014 May 27;3(5):108-110. doi: 10.1002/cld.350. eCollection 2014 May.
Abstract
摘要
相似文献
1
Role of iron in hepatocellular carcinoma.铁在肝细胞癌中的作用。
Clin Liver Dis (Hoboken). 2014 May 27;3(5):108-110. doi: 10.1002/cld.350. eCollection 2014 May.
2
Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.终末期肝病中肝铁过载的患病率及其与肝细胞癌的关联：来自国家血色素沉着症移植登记处的结果
Liver Int. 2007 Dec;27(10):1394-401. doi: 10.1111/j.1478-3231.2007.01596.x. Epub 2007 Oct 9.
3
African iron overload and hepatocellular carcinoma (HA-7-0-080).
Eur J Haematol. 1998 Jan;60(1):28-34. doi: 10.1111/j.1600-0609.1998.tb00993.x.
4
Iron metabolism gene expression and prognostic features of hepatocellular carcinoma.铁代谢基因表达与肝细胞癌的预后特征。
J Cell Biochem. 2018 Nov;119(11):9178-9204. doi: 10.1002/jcb.27184. Epub 2018 Aug 4.
5
Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver.在非肝硬化肝脏上发生肝细胞癌的患者中，肝脏铁储存增加。
Hepatology. 1995 Aug;22(2):446-50.
6
Onset of hepatocellular carcinoma in a non-cirrhotic patient affected with haemochromatosis.一名患有血色素沉着症的非肝硬化患者发生肝细胞癌。
Oncol Rep. 1998 May-Jun;5(3):723-5. doi: 10.3892/or.5.3.723.
7
Iron-free neoplastic nodules and hepatocellular carcinoma without cirrhosis in Wistar rats fed a diet high in iron.喂食高铁饮食的Wistar大鼠中无铁的肿瘤性结节和无肝硬化的肝细胞癌。
J Pathol. 2006 Jan;208(1):82-90. doi: 10.1002/path.1875.
8
The role of iron in hepatic inflammation and hepatocellular carcinoma.铁在肝脏炎症和肝细胞癌中的作用。
Free Radic Biol Med. 2019 Mar;133:200-205. doi: 10.1016/j.freeradbiomed.2018.07.006. Epub 2018 Jul 12.
9
Iron and hepatocellular carcinoma.铁与肝细胞癌
J Gastroenterol Hepatol. 2001 May;16(5):491-4. doi: 10.1046/j.1440-1746.2001.02430.x.
10
Well-differentiated hepatocellular carcinoma: isointense to liver parenchyma on superparamagnetic iron oxide-enhanced MR.
Radiat Med. 1995 Jan-Feb;13(1):35-7.
引用本文的文献
1
Global research status and frontiers on ferroptosis in hepatocellular carcinoma: a comprehensive bibliometric and visualized analysis.肝细胞癌中铁死亡的全球研究现状与前沿：一项全面的文献计量学与可视化分析
Front Immunol. 2025 May 2;16:1549600. doi: 10.3389/fimmu.2025.1549600. eCollection 2025.
2
Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target.非酒精性脂肪性肝病中的铁代谢：一个有前景的治疗靶点。
Liver Res. 2022 Sep 19;6(4):203-213. doi: 10.1016/j.livres.2022.09.003. eCollection 2022 Dec.
3
Iron Regulates Cellular Proliferation by Enhancing the Expression of Glucose Transporter GLUT3 in the Liver.铁通过增强肝脏葡萄糖转运蛋白 GLUT3 的表达来调节细胞增殖。
Cells. 2024 Jul 4;13(13):1147. doi: 10.3390/cells13131147.
4
The Effects and Safety of Silymarin on β-thalassemia in Children and Adolescents: A Systematic Review based on Clinical Trial Studies.水飞蓟素对儿童和青少年β-地中海贫血的影响和安全性：基于临床试验研究的系统评价。
Rev Recent Clin Trials. 2024;19(4):242-255. doi: 10.2174/0115748871305325240511122602.
5
Nutritional Aspects of Iron in Health and Disease.营养与健康和疾病中的铁元素
Nutrients. 2023 May 24;15(11):2441. doi: 10.3390/nu15112441.
6
Cardiac mRNA Is Predominantly Expressed in the Right Atrium and Does Not Respond to Iron.心脏 mRNA 主要在右心房表达，并且不受铁的影响。
Int J Mol Sci. 2023 Mar 8;24(6):5163. doi: 10.3390/ijms24065163.
7
Association between Hepatic Oxidative Stress Related Factors and Activation of Wnt/β-Catenin Signaling in NAFLD-Induced Hepatocellular Carcinoma.非酒精性脂肪性肝病诱导的肝细胞癌中肝脏氧化应激相关因素与Wnt/β-连环蛋白信号通路激活之间的关联
Cancers (Basel). 2022 Apr 20;14(9):2066. doi: 10.3390/cancers14092066.
8
Iron elevates mesenchymal and metastatic biomarkers in HepG2 cells.铁升高 HepG2 细胞中的间充质和转移生物标志物。
Sci Rep. 2020 Dec 14;10(1):21926. doi: 10.1038/s41598-020-78348-5.
9
Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.非酒精性脂肪性肝病相关肝细胞癌：日益受到关注。
Indian J Med Res. 2019 Jan;149(1):9-17. doi: 10.4103/ijmr.IJMR_1456_17.
10
Iron-Induced Liver Injury: A Critical Reappraisal.铁诱导性肝损伤：批判性再评价。
Int J Mol Sci. 2019 Apr 30;20(9):2132. doi: 10.3390/ijms20092132.
本文引用的文献
1
Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.与埃及丙型肝炎患者肝细胞癌进展相关的遗传变异。
Gene. 2013 Sep 25;527(2):516-20. doi: 10.1016/j.gene.2013.06.053. Epub 2013 Jul 9.
2
Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species.丙型肝炎相关的肝癌发生机制：HCV 通过调节活性氧的产生和清除来巧妙地加剧氧化应激。
Oncology. 2011;81 Suppl 1:11-7. doi: 10.1159/000333253. Epub 2011 Dec 22.
3
Effect of controlled reduction of body iron stores on clinical outcomes in peripheral arterial disease.铁储存量的控制降低对周围动脉疾病临床结果的影响。
Am Heart J. 2011 Nov;162(5):949-957.e1. doi: 10.1016/j.ahj.2011.08.013.
4
Hepatocellular carcinoma in thalassemia: A critical review.地中海贫血中的肝细胞癌：一项批判性综述。
World J Hepatol. 2010 May 27;2(5):171-4. doi: 10.4254/wjh.v2.i5.171.
5
Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis.非洲黑人的肝细胞癌：病因学和发病机制的最新进展
World J Hepatol. 2010 Feb 27;2(2):65-73. doi: 10.4254/wjh.v2.i2.65.
6
Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases.除遗传性血色素沉着症之外：铁过载与慢性肝病关系的新认识。
Dig Liver Dis. 2011 Feb;43(2):89-95. doi: 10.1016/j.dld.2010.07.006. Epub 2010 Aug 24.
7
Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis.C282Y 和 H63D 突变与欧洲人群肝癌的关系：荟萃分析。
J Exp Clin Cancer Res. 2010 Mar 2;29(1):18. doi: 10.1186/1756-9966-29-18.
8
Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis.铁依赖性调节 MDM2 影响 p53 活性和肝肿瘤发生。
Am J Pathol. 2010 Feb;176(2):1006-17. doi: 10.2353/ajpath.2010.090249. Epub 2009 Dec 17.
9
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的 HFE 基因型、实质铁积累和肝纤维化。
Gastroenterology. 2010 Mar;138(3):905-12. doi: 10.1053/j.gastro.2009.11.013. Epub 2009 Nov 18.
10
Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.髓过氧化物酶和超氧化物歧化酶2基因多态性共同调节酒精性肝硬化患者肝细胞癌发生风险及死亡风险。
Hepatology. 2009 Nov;50(5):1484-93. doi: 10.1002/hep.23187.
Zotero 插件